Association of wrist circumference with metabolic dysfunction associated fatty liver disease in the KADEM cohort

Metabolic dysfunction-associated fatty liver disease (MAFLD) is linked to metabolic dysfunction and to an increased risk of cardiovascular diseases. The early detection of individuals at high risk of MAFLD is essential for timely interventions. This study explores the association between wrist circu...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in endocrinology (Lausanne) Vol. 16; p. 1580209
Main Authors Al-Ajmi, Fahad, Abu-Farha, Mohamed, Albatineh, Ahmed N., Ali, Zahraa, AL-Enezi, Abdullah, Alterki, Mohammed, Alhammad, Rashed, AlHarbi, Retaj, Shehab, Mohamed, Abdul-Ghani, Muhammad, Abubaker, Jehad, Al-Mulla, Fahd
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 07.08.2025
Subjects
Online AccessGet full text
ISSN1664-2392
1664-2392
DOI10.3389/fendo.2025.1580209

Cover

Loading…
Abstract Metabolic dysfunction-associated fatty liver disease (MAFLD) is linked to metabolic dysfunction and to an increased risk of cardiovascular diseases. The early detection of individuals at high risk of MAFLD is essential for timely interventions. This study explores the association between wrist circumference and MAFLD among participants in the Kuwait Adult Diabetes and Epidemiological Multidisciplinary (KADEM) program, aiming to evaluate wrist circumference as a potential noninvasive diagnostic marker. This study included 449 participants assessed for MAFLD using FibroScan . The MAFLD stages were classified according to the controlled attenuation parameter (CAP) score into four groups: normal (<238 dB/m), S1 (238-260 dB/m), S2 (261-290 dB/m), and S3 (>290 dB/m). Participants underwent routine clinical blood tests, and measurements of body mass index (BMI) and wrist circumference were recorded. Multiple logistic regression was used to evaluate the discriminative ability of wrist circumference and other covariates in predicting high CAP scores, with the area under the receiver operating characteristic (ROC) curve (AUC), the sensitivity, and the specificity reported. The cohort included 184 (41.5%) normal, 77 (17.4%) S1, 81 (18.3%) S2, and 101 (22.8%) S3 participants. Wrist circumference was significantly different across groups: 16 cm for normal, 17 cm for S1 and S2, and 17.2 cm for S3 ( < 0.001). A strong correlation between wrist circumference and MAFLD was found ( = 0.328, < 0.001). Wrist circumference was positively correlated with the triglyceride (TG), alanine transaminase (ALT), and aspartate aminotransferase (AST) levels and negatively correlated with high-density lipoprotein (HDL; < 0.05). Adjusted analysis showed that gender, wrist circumference, ALT, and TG were significantly associated with high CAP scores. A multiple logistic regression model including these variables discriminated 76.3% of the subjects, with 69.4% sensitivity and 73.4% specificity. Wrist circumference is a potential noninvasive marker for the identification of individuals at high risk of MAFLD, representing a cost-effective screening tool for early detection. Further research is needed to confirm its clinical utility.
AbstractList Metabolic dysfunction-associated fatty liver disease (MAFLD) is linked to metabolic dysfunction and to an increased risk of cardiovascular diseases. The early detection of individuals at high risk of MAFLD is essential for timely interventions. This study explores the association between wrist circumference and MAFLD among participants in the Kuwait Adult Diabetes and Epidemiological Multidisciplinary (KADEM) program, aiming to evaluate wrist circumference as a potential noninvasive diagnostic marker. This study included 449 participants assessed for MAFLD using FibroScan . The MAFLD stages were classified according to the controlled attenuation parameter (CAP) score into four groups: normal (<238 dB/m), S1 (238-260 dB/m), S2 (261-290 dB/m), and S3 (>290 dB/m). Participants underwent routine clinical blood tests, and measurements of body mass index (BMI) and wrist circumference were recorded. Multiple logistic regression was used to evaluate the discriminative ability of wrist circumference and other covariates in predicting high CAP scores, with the area under the receiver operating characteristic (ROC) curve (AUC), the sensitivity, and the specificity reported. The cohort included 184 (41.5%) normal, 77 (17.4%) S1, 81 (18.3%) S2, and 101 (22.8%) S3 participants. Wrist circumference was significantly different across groups: 16 cm for normal, 17 cm for S1 and S2, and 17.2 cm for S3 ( < 0.001). A strong correlation between wrist circumference and MAFLD was found ( = 0.328, < 0.001). Wrist circumference was positively correlated with the triglyceride (TG), alanine transaminase (ALT), and aspartate aminotransferase (AST) levels and negatively correlated with high-density lipoprotein (HDL; < 0.05). Adjusted analysis showed that gender, wrist circumference, ALT, and TG were significantly associated with high CAP scores. A multiple logistic regression model including these variables discriminated 76.3% of the subjects, with 69.4% sensitivity and 73.4% specificity. Wrist circumference is a potential noninvasive marker for the identification of individuals at high risk of MAFLD, representing a cost-effective screening tool for early detection. Further research is needed to confirm its clinical utility.
IntroductionMetabolic dysfunction-associated fatty liver disease (MAFLD) is linked to metabolic dysfunction and to an increased risk of cardiovascular diseases. The early detection of individuals at high risk of MAFLD is essential for timely interventions. This study explores the association between wrist circumference and MAFLD among participants in the Kuwait Adult Diabetes and Epidemiological Multidisciplinary (KADEM) program, aiming to evaluate wrist circumference as a potential noninvasive diagnostic marker.Materials and methodsThis study included 449 participants assessed for MAFLD using FibroScan®. The MAFLD stages were classified according to the controlled attenuation parameter (CAP) score into four groups: normal (<238 dB/m), S1 (238–260 dB/m), S2 (261–290 dB/m), and S3 (>290 dB/m). Participants underwent routine clinical blood tests, and measurements of body mass index (BMI) and wrist circumference were recorded. Multiple logistic regression was used to evaluate the discriminative ability of wrist circumference and other covariates in predicting high CAP scores, with the area under the receiver operating characteristic (ROC) curve (AUC), the sensitivity, and the specificity reported.ResultsThe cohort included 184 (41.5%) normal, 77 (17.4%) S1, 81 (18.3%) S2, and 101 (22.8%) S3 participants. Wrist circumference was significantly different across groups: 16 cm for normal, 17 cm for S1 and S2, and 17.2 cm for S3 (p < 0.001). A strong correlation between wrist circumference and MAFLD was found (r = 0.328, p < 0.001). Wrist circumference was positively correlated with the triglyceride (TG), alanine transaminase (ALT), and aspartate aminotransferase (AST) levels and negatively correlated with high-density lipoprotein (HDL; p < 0.05). Adjusted analysis showed that gender, wrist circumference, ALT, and TG were significantly associated with high CAP scores. A multiple logistic regression model including these variables discriminated 76.3% of the subjects, with 69.4% sensitivity and 73.4% specificity.ConclusionWrist circumference is a potential noninvasive marker for the identification of individuals at high risk of MAFLD, representing a cost-effective screening tool for early detection. Further research is needed to confirm its clinical utility.
Author Abdul-Ghani, Muhammad
Ali, Zahraa
AlHarbi, Retaj
Albatineh, Ahmed N.
Abubaker, Jehad
Alterki, Mohammed
Al-Ajmi, Fahad
Shehab, Mohamed
Al-Mulla, Fahd
AL-Enezi, Abdullah
Abu-Farha, Mohamed
Alhammad, Rashed
AuthorAffiliation 5 Division of Diabetes, University of Texas Health Science Center , San Antonio, TX ,  United States
1 Department of Biochemistry and Molecular Biology, Dasman Diabetes Institute , Dasman ,  Kuwait
3 Department of Biostatistics and Health Data Science, College of Health, Lehigh University , Bethlehem, PA ,  United States
4 Department of Pharmacology, Faculty of Medicine, Kuwait University , Kuwait City ,  Kuwait
2 Department of Translational Research, Dasman Diabetes Institute , Dasman ,  Kuwait
AuthorAffiliation_xml – name: 1 Department of Biochemistry and Molecular Biology, Dasman Diabetes Institute , Dasman ,  Kuwait
– name: 4 Department of Pharmacology, Faculty of Medicine, Kuwait University , Kuwait City ,  Kuwait
– name: 3 Department of Biostatistics and Health Data Science, College of Health, Lehigh University , Bethlehem, PA ,  United States
– name: 2 Department of Translational Research, Dasman Diabetes Institute , Dasman ,  Kuwait
– name: 5 Division of Diabetes, University of Texas Health Science Center , San Antonio, TX ,  United States
Author_xml – sequence: 1
  givenname: Fahad
  surname: Al-Ajmi
  fullname: Al-Ajmi, Fahad
– sequence: 2
  givenname: Mohamed
  surname: Abu-Farha
  fullname: Abu-Farha, Mohamed
– sequence: 3
  givenname: Ahmed N.
  surname: Albatineh
  fullname: Albatineh, Ahmed N.
– sequence: 4
  givenname: Zahraa
  surname: Ali
  fullname: Ali, Zahraa
– sequence: 5
  givenname: Abdullah
  surname: AL-Enezi
  fullname: AL-Enezi, Abdullah
– sequence: 6
  givenname: Mohammed
  surname: Alterki
  fullname: Alterki, Mohammed
– sequence: 7
  givenname: Rashed
  surname: Alhammad
  fullname: Alhammad, Rashed
– sequence: 8
  givenname: Retaj
  surname: AlHarbi
  fullname: AlHarbi, Retaj
– sequence: 9
  givenname: Mohamed
  surname: Shehab
  fullname: Shehab, Mohamed
– sequence: 10
  givenname: Muhammad
  surname: Abdul-Ghani
  fullname: Abdul-Ghani, Muhammad
– sequence: 11
  givenname: Jehad
  surname: Abubaker
  fullname: Abubaker, Jehad
– sequence: 12
  givenname: Fahd
  surname: Al-Mulla
  fullname: Al-Mulla, Fahd
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40852186$$D View this record in MEDLINE/PubMed
BookMark eNpVkdFOHCEUhomxUWt9gV40vMBu4cAwcNVsrFWjTW_aa8IwBxczO2yA1ezbd9xdjXIuIJz__26-z-R4TCMS8pWzuRDafA849mkODJo5bzQDZo7IGVdKzkAYOH73PiUXpTyy6UjGjdEn5FQy3QDX6oysF6UkH12NaaQp0OccS6U-Zr9ZBcw4eqTPsS7pCqvr0hA97bclbEa_a7hDG3saXK1bOsQnzLSPBV1BGkdal0jvFj-vflOflinXL-RTcEPBi8N9Tv79uvp7eTO7_3N9e7m4n3nBpJlB47QHxlkAJ7nqey1aUEZr5yWX0ojWsM4L5Uww0ngHSrnOBM5BK2g5inNyu-f2yT3adY4rl7c2uWh3Hyk_WJdr9ANa3nSqE9MAMNkEMB2oXmKrmESBUk2sH3vWetOtsPc41uyGD9CPmzEu7UN6shyEaqU2E-Hbe8Jb9VXEFIB9wOdUSsbwFuHMvgi3O-H2Rbg9CBf_AdO7n40
Cites_doi 10.1186/s12889-021-12371-7
10.1007/s42000-022-00377-8
10.1186/1758-5996-2-65
10.1186/s13098-021-00741-5
10.3390/livers3040040
10.1016/j.athplu.2023.08.001
10.1007/s40618-019-01086-7
10.3390/diagnostics13030488
10.1186/s12944-019-0984-9
10.1186/s12916-023-03080-6
10.3390/ijerph21050549
10.1186/s12876-022-02576-4
10.3390/biology11081237
10.1186/s12944-022-01748-1
10.1016/j.diabres.2017.11.003
10.3389/fmed.2021.770504
10.1177/20420188221139614
10.1016/j.atherosclerosis.2013.01.022
10.1016/j.jhep.2020.03.039
10.1186/s12876-024-03190-2
10.1186/s12902-020-00559-8
10.1002/hep4.1990
10.33963/KP.a2023.0112
10.1590/S0004-2803.202100000-80
ContentType Journal Article
Copyright Copyright © 2025 Al-Ajmi, Abu-Farha, Albatineh, Ali, AL-Enezi, Alterki, Alhammad, AlHarbi, Shehab, Abdul-Ghani, Abubaker and Al-Mulla.
Copyright © 2025 Al-Ajmi, Abu-Farha, Albatineh, Ali, AL-Enezi, Alterki, Alhammad, AlHarbi, Shehab, Abdul-Ghani, Abubaker and Al-Mulla. 2025 Al-Ajmi, Abu-Farha, Albatineh, Ali, AL-Enezi, Alterki, Alhammad, AlHarbi, Shehab, Abdul-Ghani, Abubaker and Al-Mulla
Copyright_xml – notice: Copyright © 2025 Al-Ajmi, Abu-Farha, Albatineh, Ali, AL-Enezi, Alterki, Alhammad, AlHarbi, Shehab, Abdul-Ghani, Abubaker and Al-Mulla.
– notice: Copyright © 2025 Al-Ajmi, Abu-Farha, Albatineh, Ali, AL-Enezi, Alterki, Alhammad, AlHarbi, Shehab, Abdul-Ghani, Abubaker and Al-Mulla. 2025 Al-Ajmi, Abu-Farha, Albatineh, Ali, AL-Enezi, Alterki, Alhammad, AlHarbi, Shehab, Abdul-Ghani, Abubaker and Al-Mulla
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
5PM
DOA
DOI 10.3389/fendo.2025.1580209
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1664-2392
ExternalDocumentID oai_doaj_org_article_15b6b3b3b22045f29b26d4e7604e3e46
PMC12367489
40852186
10_3389_fendo_2025_1580209
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M~E
OK1
PGMZT
RPM
CGR
CUY
CVF
ECM
EIF
IPNFZ
M48
NPM
RIG
5PM
ID FETCH-LOGICAL-c3049-25a8c2010f2a416dd83726988ac414493790bc36a9f949ca266ab9f11286271e3
IEDL.DBID DOA
ISSN 1664-2392
IngestDate Wed Aug 27 01:28:39 EDT 2025
Sat Aug 23 05:22:16 EDT 2025
Thu Sep 04 04:56:48 EDT 2025
Thu Aug 14 00:04:17 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords MAFLD
CAP
wrist circumference
obesity
T2D
Language English
License Copyright © 2025 Al-Ajmi, Abu-Farha, Albatineh, Ali, AL-Enezi, Alterki, Alhammad, AlHarbi, Shehab, Abdul-Ghani, Abubaker and Al-Mulla.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3049-25a8c2010f2a416dd83726988ac414493790bc36a9f949ca266ab9f11286271e3
Notes Md Hasif Sinha, University of Louisville, United States
These authors have contributed equally to this work
Edited by: Rashu Barua, New York University, United States
Reviewed by: Raffaele Carraro, La Princesa University Hospital, Spain
Md Saqline Mostaq, University of Louisiana at Monroe, United States
Mohammad Irfan Dar, Jamia Millia Islamia, India
OpenAccessLink https://doaj.org/article/15b6b3b3b22045f29b26d4e7604e3e46
PMID 40852186
ParticipantIDs doaj_primary_oai_doaj_org_article_15b6b3b3b22045f29b26d4e7604e3e46
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12367489
pubmed_primary_40852186
crossref_primary_10_3389_fendo_2025_1580209
PublicationCentury 2000
PublicationDate 20250807
PublicationDateYYYYMMDD 2025-08-07
PublicationDate_xml – month: 8
  year: 2025
  text: 20250807
  day: 7
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in endocrinology (Lausanne)
PublicationTitleAlternate Front Endocrinol (Lausanne)
PublicationYear 2025
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Pereira (B22) 2024; 21
Wang (B13) 2022; 6
Chandra Kumar (B14) 2022; 13
Yozgat (B20) 2021; 58
Feng (B8) 2023; 13
Jia (B3) 2023; 21
Mousapour (B11) 2021; 21
Karami (B21) 2021; 13
Esteghamati (B17) 2010; 2
Ren (B18) 2019; 18
Luordi (B23) 2020; 43
Shi (B10) 2020; 20
Hoekstra (B16) 2023; 53
Eslam (B2) 2020; 73
Kechagias (B15) 2022; 21
Li (B7) 2024; 24
DeFilippis (B19) 2013; 227
Doganay (B24) 2023; 81
Francisco (B9) 2022; 11
Liu (B1) 2022; 22
Bhopale (B4) 2023; 3
Low (B5) 2018; 138
Zou (B12) 2022; 21
Rodriguez-Sanabria (B6) 2021; 8
References_xml – volume: 21
  start-page: 2276
  year: 2021
  ident: B11
  article-title: Wrist circumference as a novel predictor of transition from metabolically healthy to unhealthy phenotype in overweight/obese adults: a gender-stratified 15.5-year follow-up
  publication-title: BMC Public Health
  doi: 10.1186/s12889-021-12371-7
– volume: 21
  year: 2022
  ident: B15
  article-title: Non-invasive diagnosis and staging of non-alcoholic fatty liver disease
  publication-title: Hormones (Athens)
  doi: 10.1007/s42000-022-00377-8
– volume: 2
  start-page: 65
  year: 2010
  ident: B17
  article-title: Metabolic syndrome is linked to a mild elevation in liver aminotransferases in diabetic patients with undetectable non-alcoholic fatty liver disease by ultrasound
  publication-title: Diabetol Metab Syndr
  doi: 10.1186/1758-5996-2-65
– volume: 13
  start-page: 121
  year: 2021
  ident: B21
  article-title: Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
  publication-title: Diabetol Metab Syndr
  doi: 10.1186/s13098-021-00741-5
– volume: 3
  start-page: 597
  year: 2023
  ident: B4
  article-title: Therapeutics for metabolic dysfunction-associated fatty liver disease (MAFLD)
  publication-title: Livers
  doi: 10.3390/livers3040040
– volume: 53
  start-page: 33
  year: 2023
  ident: B16
  article-title: High-density lipoproteins and non-alcoholic fatty liver disease
  publication-title: Atheroscler Plus
  doi: 10.1016/j.athplu.2023.08.001
– volume: 43
  year: 2020
  ident: B23
  article-title: Wrist circumference is a biomarker of adipose tissue dysfunction and cardiovascular risk in children with obesity
  publication-title: J Endocrinol Invest
  doi: 10.1007/s40618-019-01086-7
– volume: 13
  start-page: 488
  year: 2023
  ident: B8
  article-title: Changes in clinical manifestations due to AFLD retyping based on the new MAFLD criteria: an observational study based on the national inpatient sample database
  publication-title: Diagnostics
  doi: 10.3390/diagnostics13030488
– volume: 18
  start-page: 47
  year: 2019
  ident: B18
  article-title: Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study
  publication-title: Lipids Health Dis
  doi: 10.1186/s12944-019-0984-9
– volume: 21
  start-page: 398
  year: 2023
  ident: B3
  article-title: Multi-system diseases and death trajectory of metabolic dysfunction-associated fatty liver disease: findings from the UK Biobank
  publication-title: BMC Med
  doi: 10.1186/s12916-023-03080-6
– volume: 21
  start-page: 549
  year: 2024
  ident: B22
  article-title: Wrist circumference cutoff points for determining excess weight levels and predicting cardiometabolic risk in adults
  publication-title: Int J Environ Res Public Health
  doi: 10.3390/ijerph21050549
– volume: 22
  start-page: 471
  year: 2022
  ident: B1
  article-title: A comparison of NAFLD and MAFLD diagnostic criteria in contemporary urban healthy adults in China: a cross-sectional study
  publication-title: BMC Gastroenterol
  doi: 10.1186/s12876-022-02576-4
– volume: 11
  year: 2022
  ident: B9
  article-title: Adipokines in non-alcoholic fatty liver disease: are we on the road toward new biomarkers and therapeutic targets
  publication-title: Biol (Basel)
  doi: 10.3390/biology11081237
– volume: 21
  start-page: 133
  year: 2022
  ident: B12
  article-title: Development and validation of a new nomogram to screen for MAFLD
  publication-title: Lipids Health Dis
  doi: 10.1186/s12944-022-01748-1
– volume: 138
  start-page: 8
  year: 2018
  ident: B5
  article-title: Discovery and validation of serum creatinine variability as novel biomarker for predicting onset of albuminuria in Type 2 diabetes mellitus
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2017.11.003
– volume: 8
  year: 2021
  ident: B6
  article-title: An update in epigenetics in metabolic-associated fatty liver disease
  publication-title: Front Med (Lausanne)
  doi: 10.3389/fmed.2021.770504
– volume: 13
  start-page: 20420188221139614
  year: 2022
  ident: B14
  article-title: Non-invasive assessment of metabolic dysfunction-associated fatty liver disease
  publication-title: Ther Adv Endocrinol Metab
  doi: 10.1177/20420188221139614
– volume: 227
  year: 2013
  ident: B19
  article-title: Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2013.01.022
– volume: 73
  year: 2020
  ident: B2
  article-title: A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2020.03.039
– volume: 24
  start-page: 109
  year: 2024
  ident: B7
  article-title: Using new indices to predict metabolism dysfunction-associated fatty liver disease (MAFLD): analysis of the national health and nutrition examination survey database
  publication-title: BMC Gastroenterol
  doi: 10.1186/s12876-024-03190-2
– volume: 20
  start-page: 78
  year: 2020
  ident: B10
  article-title: Large mid-upper arm circumference is associated with metabolic syndrome in middle-aged and elderly individuals: a community-based study
  publication-title: BMC Endocr Disord
  doi: 10.1186/s12902-020-00559-8
– volume: 6
  year: 2022
  ident: B13
  article-title: Mid-upper arm circumference is associated with liver steatosis and fibrosis in patients with metabolic-associated fatty liver disease: A population based observational study
  publication-title: Hepatol Commun
  doi: 10.1002/hep4.1990
– volume: 81
  year: 2023
  ident: B24
  article-title: Association between the visceral adiposity index and the coronary artery calcification score and atherosclerotic plaque morphology
  publication-title: Kardiol Pol
  doi: 10.33963/KP.a2023.0112
– volume: 58
  year: 2021
  ident: B20
  article-title: Monocyte/hdl ratio in non-alcoholic hepatic steatosis
  publication-title: Arq Gastroenterol
  doi: 10.1590/S0004-2803.202100000-80
SSID ssj0000401998
Score 2.3748767
Snippet Metabolic dysfunction-associated fatty liver disease (MAFLD) is linked to metabolic dysfunction and to an increased risk of cardiovascular diseases. The early...
IntroductionMetabolic dysfunction-associated fatty liver disease (MAFLD) is linked to metabolic dysfunction and to an increased risk of cardiovascular...
SourceID doaj
pubmedcentral
pubmed
crossref
SourceType Open Website
Open Access Repository
Index Database
StartPage 1580209
SubjectTerms Adult
Aged
Biomarkers
Body Mass Index
CAP
Cohort Studies
Endocrinology
Fatty Liver - epidemiology
Female
Humans
MAFLD
Male
Metabolic Diseases - complications
Middle Aged
Non-alcoholic Fatty Liver Disease - epidemiology
obesity
ROC Curve
T2D
Wrist - anatomy & histology
wrist circumference
Title Association of wrist circumference with metabolic dysfunction associated fatty liver disease in the KADEM cohort
URI https://www.ncbi.nlm.nih.gov/pubmed/40852186
https://pubmed.ncbi.nlm.nih.gov/PMC12367489
https://doaj.org/article/15b6b3b3b22045f29b26d4e7604e3e46
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT4NAEN6YHowX49v6yh68GSwsy2OPaqyNpp5s0htZ9hFJWtpUGtN_78yCDZy8GBIOsMDyfcDMMLvfEHKbKM2MQSnEwJceZ9b3pLXW09Iyo3ydWyeSNH6PRxP-Oo2mrVJfOCaslgeugRsEUR7nISwMhdMtEzmLNTdJ7HMTGu7EtsHmtYIp9w2GsAECiXqWDERhYmBNqXGyH4vugygFJ0l0LJET7G9Zoe4IyZbJGR6Q_cZXpA91Hw_JjimPyO64yYYfk2ULW7qw9BtfWKqKlVrPm2l8FP-z0rmpgOtZoajefKElc0fI5mijqZVVtaEzHKNBm5QNLUoKziF9Q6oo1tFdVSdkMnz-eBp5TQUFT2H6zGORTBXmuy2T4HlpDeEoi0WaSsUhkgLXRPi5CmMprOBCSbDWMhcWfDAIdJLAhKekVy5Kc05oogFTEzFolHDFgMsgibHMr_BVajTvk7tfNLNlLZSRQYCB2GcO-wyxzxrs--QRAd-2RJFrtwGozxrqs7-o75OzmqXtaVCuDYts9Una4a9zne6esvh0otpOyo6n4uI_enZJ9vBu3UDB5Ir0qtXaXIPzUuU37jmF9cs0-AGY_O6U
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+wrist+circumference+with+metabolic+dysfunction+associated+fatty+liver+disease+in+the+KADEM+cohort&rft.jtitle=Frontiers+in+endocrinology+%28Lausanne%29&rft.au=Al-Ajmi%2C+Fahad&rft.au=Abu-Farha%2C+Mohamed&rft.au=Albatineh%2C+Ahmed+N&rft.au=Ali%2C+Zahraa&rft.date=2025-08-07&rft.issn=1664-2392&rft.eissn=1664-2392&rft.volume=16&rft.spage=1580209&rft_id=info:doi/10.3389%2Ffendo.2025.1580209&rft_id=info%3Apmid%2F40852186&rft.externalDocID=40852186
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-2392&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-2392&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-2392&client=summon